Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Medical University of Vienna

Medical University of Vienna in Vienna, Austria is listed as a site for 550 registered clinical trials, 121 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 550
Ongoing 121

This page covers the site record Medical University of Vienna in Vienna, Austria: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Medical University of Vienna, also sponsors trials.

Get the Medical University of Vienna report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 550 trials counted.

  • Phase 1 27 trials
  • Phase 1/2 6 trials
  • Phase 2 56 trials
  • Phase 2/3 12 trials
  • Phase 3 65 trials
  • Phase 4 30 trials
  • Not applicable 165 trials
  • Observational 187 trials
  • Expanded access 2 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 121 trials
  • Completed 276 trials
  • Terminated 36 trials
  • Other 117 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 46

1998: 1 trials (Phase 3 1) 2000: 1 trials (Observational 1) 2002: 4 trials (Observational 1, Not applicable 1, Phase 4 2) 2004: 2 trials (Not applicable 1, Phase 4 1) 2005: 5 trials (Not applicable 2, Phase 3 2, Phase 2/3 1) 2006: 9 trials (Observational 2, Not applicable 2, Phase 4 2, Phase 3 3) 2007: 13 trials (Observational 4, Not applicable 2, Phase 3 4, Phase 2/3 1, Phase 2 1, Phase 1 1) 2008: 10 trials (Observational 3, Not applicable 3, Phase 4 1, Phase 2 3) 2009: 9 trials (Observational 2, Not applicable 1, Phase 3 3, Phase 2 3) 2010: 18 trials (Observational 3, Not applicable 6, Phase 4 4, Phase 3 2, Phase 2/3 1, Phase 2 1, Phase 1 1) 2011: 23 trials (Observational 7, Not applicable 5, Phase 4 1, Phase 3 4, Phase 2/3 1, Phase 2 4, Phase 1/2 1) 2012: 17 trials (Observational 5, Not applicable 6, Phase 4 2, Phase 3 3, Phase 2 1) 2013: 18 trials (Observational 7, Not applicable 5, Phase 4 2, Phase 3 2, Phase 2 1, Phase 1 1) 2014: 18 trials (Observational 7, Not applicable 6, Phase 3 1, Phase 2/3 1, Phase 2 3) 2015: 21 trials (Observational 6, Not applicable 10, Phase 4 1, Phase 3 1, Phase 2 1, Phase 1 2) 2016: 27 trials (Observational 8, Not applicable 6, Phase 3 1, Phase 2/3 3, Phase 2 5, Phase 1/2 2, Phase 1 2) 2017: 42 trials (Observational 18, Not applicable 12, Phase 4 4, Phase 3 2, Phase 2 4, Phase 1 2) 2018: 40 trials (Observational 17, Not applicable 9, Phase 4 1, Phase 3 8, Phase 2 2, Phase 1 3) 2019: 39 trials (Observational 17, Not applicable 13, Phase 4 1, Phase 3 3, Phase 2 2, Phase 1/2 2, Phase 1 1) 2020: 46 trials (Observational 23, Not applicable 10, Phase 4 1, Phase 3 3, Phase 2/3 1, Phase 2 6, Phase 1 2) 2021: 46 trials (Observational 17, Not applicable 19, Phase 3 1, Phase 2 4, Phase 1/2 1, Phase 1 4) 2022: 25 trials (Observational 4, Not applicable 8, Phase 4 3, Phase 3 2, Phase 2/3 1, Phase 2 3, Phase 1 4) 2023: 40 trials (Observational 13, Not applicable 15, Phase 4 2, Phase 3 5, Phase 2 3, Phase 1 2) 2024: 38 trials (Observational 11, Not applicable 12, Phase 4 1, Phase 3 9, Phase 2 5) 2025: 17 trials (Observational 5, Not applicable 6, Phase 4 1, Phase 3 1, Phase 2/3 1, Phase 2 2, Phase 1 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 15
2025 17
2024 38
2023 40
2022 25
2021 46
2020 46
2019 39
2018 40
2017 42

Showing 10 of 26 years.

Start your 14-day trial Email me all 26 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 550 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 105 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 330 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF